Search

everythinglearnresearchcommunity

for

Search:↓

Certain factors like being female, having high cholesterol, using Medicaid, and previous non-biologic treatments increase the risk of multiple biologic failures in psoriasis patients.

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

JAK inhibitors can help treat alopecia areata but have risks and high costs.

Elderly skin care needs personalized treatment, early intervention, and integrated psychiatric care.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

The treatment cleared psoriasis in some patients but caused side effects in most.

Pityriasis rubra pilaris significantly worsens quality of life more than many other health conditions.

Ro 10-9359 is an effective treatment for severe psoriasis but can cause side effects.

Patients with psoriasis ranked symptom control and treatment efficacy as most important for their care.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.

PRP patients show varied symptoms and need more research to understand related conditions.

The care model improved timely diagnosis and treatment for psoriasis and psoriatic arthritis.

Isotretinoin effectively improved severe pityriasis rubra pilaris with complications.

Retinoids help treat psoriasis effectively, but they can cause side effects and need more research on safe use with other treatments.

The VSCAPSI is a helpful method for evaluating the severity of scalp psoriasis.

The study created a 27-item measure to assess the impact of skin diseases.

Psoriasis patients experience moderate functional impairment related to disease severity and less satisfaction.

Tofacitinib may be an effective and safe treatment for adolescent alopecia areata.

Including special area involvement helps identify more psoriasis patients who may need systemic treatment.

The Facial Psoriasis Log-based Area and Severity Index is a more effective way to measure improvements in facial psoriasis than the traditional method.

Patients with skin diseases rated psychological effects as most impactful, needing a treatment approach that addresses both mind and body.

Dermoscopic features can help identify and differentiate types of pityriasis versicolor.

Platelet-rich plasma treatment may safely and effectively reduce skin lesions in psoriasis and atopic dermatitis.

Ruxolitinib cream shows promise for vitiligo, and early melanoma diagnosis is crucial.

Systemic retinoids are effective for psoriasis but have side effects; benefits may outweigh risks, especially when reducing cancer risks from other treatments.

Psoriasis involves an imbalance between certain immune cells, and targeting these could help restore skin health.